EUnetHTA Conference: HTA's Future in Europe

November 20, 2008
Pasteur Institute, Paris, France
Health technology is the application of scientific knowledge in health care and prevention. Health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value.

Detailed programme will be available at a later date. To receive updated information regarding the conference, please subscribe to the update service at http://www.eunethta.net/Home/
EUnetHTA_Conference_2008_in__Paris/

The plenary will include presentations on the results from the EUnetHTA project:

  • Core HTA Model
  • HTA Adaptation toolkit
  • New technologies monitoring system
  • Emerging technologies information system
  • HTA and health policy
  • HTA capacity building
  • EUnetHTA HTA information system

The Conference will be held at the Scientific International Center of the Pasteur Institute.
These facilities are conveniently located downtown Paris (Metro Pasteur; Gare Montparnasse)
The official language of the conference is English. Simultaneous interpretation will be available in French and Spanish.

For further information, please visit:
http://www.eunethta.net/Home/
EUnetHTA_Conference_HTAs_Future_in_Europe/

About European network for Health Technology Assessment (EUnetHTA)
In 2004 the European Commission and Council of Ministers targeted Health Technology Assessment (HTA) as "a political priority", recognising "...an urgent need for establishing a sustainable European network on HTA". A Commission call was answered in 2005 by a group of 35 organisations throughout Europe, led by the Danish Centre for Evaluation and HTA (DACEHTA) in Copenhagen.

European network for Health Technology Assessment, EUnetHTA, coordinates the efforts of 27 European countries including 25 Member States of the European Union in evaluating health technology in Europe.

The general strategic objective of the Network:
to connect public national/regional HTA agencies, research institutions and health ministries, enabling an effective exchange of information and support to policy decisions by the Member States. Specific Objectives...

During the first 3 years of existence (2006-2008) EUnetHTA aims at developing an organisational framework for a sustainable European network for HTA along with practical tools to fill into this framework to ensure timely and effective production, dissemination and transfer of HTA results into useful policy advice to the Member States and EU.

Initially, the EUnetHTA project is being co-financed by the European Commission (DG Sanco) and contributions from network members.

Progress reports and information on EUnetHTA activities involving a wider stakeholder group will be continuously available on the Eunethta website, http://www.eunethta.net.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...